58.71

1.81% -1.1939

Bio Techne Corp (TECH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Bio Techne Corp stock is traded at $58.71, with a volume of 751.35K. It is down -1.81% in the last 24 hours and up +15.41% over the past month. Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Previous Close:

$59.90

Open:

$59.95

24h Volume:

751.35K

Relative Volume:

0.32

Market Cap:

$9.14B

Revenue:

$1.17B

Net Income/Loss:

$150.71M

P/E Ratio:

62.45

EPS:

0.94

Net Cash Flow:

$245.03M

1W Performance:

-6.57%

1M Performance:

+15.41%

6M Performance:

+19.40%

1Y Performance:

-19.41%

1-Day Range:

$57.85

$60.07

1-Week Range:

$57.85

$63.28

52-Week Range:

$46.01

$80.80

Bio Techne Corp Stock (TECH) Company Profile

Name

Bio Techne Corp

Sector

Healthcare (1149)

Industry

Biotechnology (638)

Phone

(612) 379-8854

Address

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Employee

3,100

Twitter

@biotechne

Next Earnings Date

2024-10-30

Latest SEC Filings

TECH's Discussions on Twitter

Compare TECH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TECH Bio Techne Corp	58.67	9.33B	1.17B	150.71M	245.03M	0.94
VRTX Vertex Pharmaceuticals Inc	407.43	106.37B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	457.28	59.90B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	559.05	60.40B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	796.84	49.56B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	321.49	36.88B	4.56B	-176.77M	225.30M	-1.7177

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-03-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Aug-21-25	Upgrade	Citigroup	Neutral → Buy
Jul-22-25	Resumed	Stephens	Overweight
Jul-09-25	Initiated	TD Cowen	Buy
May-30-25	Initiated	Wells Fargo	Overweight
Apr-09-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-18-25	Initiated	Evercore ISI	Outperform
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral
May-22-24	Downgrade	Citigroup	Buy → Neutral
Feb-08-24	Initiated	Scotiabank	Sector Outperform
Feb-02-24	Downgrade	Stifel	Buy → Hold
Dec-07-23	Initiated	UBS	Buy
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-12-22	Upgrade	Citigroup	Neutral → Buy
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform
Aug-25-22	Initiated	Credit Suisse	Outperform
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight
Feb-23-21	Upgrade	Stifel	Hold → Buy
Jan-25-21	Reiterated	The Benchmark Company	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-30-20	Initiated	Atlantic Equities	Overweight
Jul-15-20	Downgrade	Stephens	Overweight → Equal-Weight
May-27-20	Downgrade	Stifel	Buy → Hold
May-14-20	Initiated	The Benchmark Company	Buy
Jan-08-20	Resumed	Stephens	Overweight
Jan-08-20	Initiated	Wells Fargo	Equal Weight
Jan-07-20	Initiated	Citigroup	Neutral
Nov-15-19	Initiated	Stifel	Buy
Jul-02-19	Upgrade	Janney	Neutral → Buy
Jan-14-19	Upgrade	Stephens	Equal-Weight → Overweight
Oct-31-18	Downgrade	Craig Hallum	Buy → Hold
Oct-17-18	Initiated	Goldman	Neutral
Jun-15-18	Initiated	Argus	Buy
Jul-13-17	Initiated	Wells Fargo	Market Perform
Feb-09-17	Initiated	Citigroup	Buy
Jan-18-17	Initiated	Deutsche Bank	Buy
Nov-10-16	Resumed	Leerink Partners	Outperform
Jan-21-15	Reiterated	Robert W. Baird	Outperform
Sep-20-13	Upgrade	Robert W. Baird	Neutral → Outperform

View All

Bio Techne Corp Stock (TECH) Latest News

07:17 AM

Bio-Techne (TECH): Valuation Spotlight Following Expanded Oxford Nanopore Partnership and Growth Strategy Realignment - Yahoo Finance

07:17 AM

06:47 AM

Visual analytics tools that track Bio Techne Corporation performance2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com

06:47 AM

06:21 AM

Bio Techne Corporation stock daily chart insightsEarnings Growth Report & Smart Investment Allocation Insights - newser.com

06:21 AM

03:25 AM

Can Bio Techne Corporation recover in the next quarterWeekly Stock Summary & Verified Momentum Stock Alerts - newser.com

03:25 AM

02:34 AM

Will Bio Techne Corporation stock deliver shareholder valueJuly 2025 Momentum & Technical Pattern Based Signals - newser.com

02:34 AM

Oct 09, 2025

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 - Investing News Network

Oct 09, 2025

Bio-Techne (TECH) Expands Partnership with Oxford Nanopore Technologies - GuruFocus

Oct 09, 2025

Bio-techne expands genetic testing collaboration with Oxford Nanopore - Investing.com

Oct 09, 2025

Is Bio Techne Corporation (TE1) stock resilient in recession scenariosTrade Entry Report & Reliable Price Action Trade Plans - newser.com

Oct 09, 2025

Oct 08, 2025

Should You Continue to Hold Bio-Techne Stock in Your Portfolio? - sharewise.com

Oct 08, 2025

Citi Sticks to Their Buy Rating for Bio-Techne (TECH) - The Globe and Mail

Oct 08, 2025

Oct 07, 2025

Evercore ISI Group Raises Bio-Techne (TECH) Price Target to $72 | TECH Stock News - GuruFocus

Oct 07, 2025

Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo

Oct 07, 2025

Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

Oct 07, 2025

Evercore ISI Group Raises Bio-Techne (TECH) Price Target to $72 - GuruFocus

Oct 07, 2025

Citi Maintains Bio-Techne(TECH.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛

Oct 07, 2025

Oct 06, 2025

How Bio Techne Corporation stock performs in rate cut cyclesTrade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com

Oct 06, 2025

Oct 05, 2025

Will Bio-Techne's (TECH) Latest Spatial Biology Tools Reshape Its Edge in Translational Research? - simplywall.st

Oct 05, 2025

Bio-Techne (TECH) Surges Over 21% as Healthcare Stocks Rally - GuruFocus

Oct 05, 2025

Bio Techne Corporation stock volume spike explained2025 Trade Ideas & Daily Profit Focused Stock Screening - newser.com

Oct 05, 2025

Oct 04, 2025

Bio-Techne Corp. Hits Day High with 10.2% Surge in Strong Intraday Performance - Markets Mojo

Oct 04, 2025

Oct 03, 2025

Bio-Techne (TECH): Assessing the Valuation as Shares Continue Their Recent Upward Momentum - simplywall.st

Oct 03, 2025

Why Bio Techne Corporation (TE1) stock trades below fair value2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com

Oct 03, 2025

Oct 02, 2025

Can Bio Techne Corporation (TE1) stock beat analyst consensusWeekly Market Report & Low Risk Entry Point Guides - newser.com

Oct 02, 2025

Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know - The Globe and Mail

Oct 02, 2025

Could Spatial Biology Advances Shape Bio-Techne's (TECH) Long-Term Position in Precision Medicine? - Yahoo Finance

Oct 02, 2025

Bio-Techne Corp. stock outperforms competitors on strong trading day - MSN

Oct 02, 2025

Oct 01, 2025

The Best Biotech Stocks to Buy - Morningstar

Oct 01, 2025

Sep 30, 2025

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know - Yahoo Finance

Sep 30, 2025

Bio-Techne (TECH) Shares Skyrocket, What You Need To Know - Yahoo Finance

Sep 30, 2025

What analysts say about Bio Techne Corporation TE1 stockIPO Market Watch & Free Discover Dynamic Stocks - earlytimes.in

Sep 30, 2025

Sep 29, 2025

Is Bio Techne Corporation (TE1) stock positioned for secular growthDollar Strength & Real-Time Buy Signal Alerts - newser.com

Sep 29, 2025

Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions - The Globe and Mail

Sep 29, 2025